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Abstract
A hallmark of immune cell trafficking is directional guidance via gradients of soluble or surface bound chemokines. Vascular
endothelial cells produce, transport and deposit either their own chemokines or chemokines produced by the underlying
stroma. Endothelial heparan sulfate (HS) was suggested to be a critical scaffold for these chemokine pools, but it is unclear
how steep chemokine gradients are sustained between the lumenal and ablumenal aspects of blood vessels. Addressing
this question by semi-quantitative immunostaining of HS moieties around blood vessels with a pan anti-HS IgM mAb, we
found a striking HS enrichment in the basal lamina of resting and inflamed post capillary skin venules, as well as in high
endothelial venules (HEVs) of lymph nodes. Staining of skin vessels with a glycocalyx probe further suggested that their
lumenal glycocalyx contains much lower HS density than their basolateral extracellular matrix (ECM). This polarized HS
pattern was observed also in isolated resting and inflamed microvascular dermal cells. Notably, progressive skin
inflammation resulted in massive ECM deposition and in further HS enrichment around skin post capillary venules and their
associated pericytes. Inflammation-dependent HS enrichment was not compromised in mice deficient in the main HS
degrading enzyme, heparanase. Our results suggest that the blood vasculature patterns steep gradients of HS scaffolds
between their lumenal and basolateral endothelial aspects, and that inflammatory processes can further enrich the HS
content nearby inflamed vessels. We propose that chemokine gradients between the lumenal and ablumenal sides of
vessels could be favored by these sharp HS scaffold gradients.
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Introduction
Chemokines are structurally related chemotactic cytokines
which guide the adhesion and motility of many cell types including
immune cells [1,2]. Based on in vitro studies, it has been
traditionally believed that chemokines guide leukocyte chemotaxis
via gradients of soluble molecules [3]. Nevertheless, the most fully
established in vivo example of chemokine function is leukocyte
arrest on blood vessels, a chemokine-driven process that requires
immobilized chemokines, but does not depend on a chemokine
gradient or on soluble chemokines [4].
Unlike lipid chemoattractants, which operate in their mem-
brane bound lipophilic forms [5–7], most chemokines share high
affinity binding sites for HS glycosaminoglycans (GAGs) [8]. These
sites do not overlap or compete with chemokine binding to their
G-protein coupled receptors (GPCRs) [8,9], and thus, chemokine
presentation by HS scaffolds not only retains, but in many cases
augments, GPCR signaling on adherent or motile leukocytes
[10,11]. The in vivo relevance of HS dependent presentation of
chemokines to immune cells recruited by blood vessels has been
demonstrated either indirectly by competition assays [12] or
directly, by in vivo or ex vivo enzymatic removal of HS moieties [13–
15]. Genetic evidence for the key roles of HS GAGs in vascular
presentation of key leukocyte chemokines to adherent and
migratory leukocytes was provided by two milestone studies
[13,16]. In vivo involvement of endothelial HS in inflammation was
first demonstrated by endothelial-targeted ablation of the enzyme
required for N-sulfation of HS GAGs, which resulted in attenuated
neutrophil infiltration to sites of inflammation [16]. In a
subsequent study, conditional endothelial specific deletion of the
main enzyme that initiates HS GAG biosynthesis, Ext1, led to
total loss of HEV HS, eliminated both CCL21 and CCL2
presentation on resting and inflamed lymph nodes, respectively,
and reduced the presentation of the neutrophil-specific chemo-
kine, CXCL1, on inflamed skin vessels [13]. Loss of lymphatic
endothelial HS in Ext1-deficient lymphatic vessels also impaired
both CCL21 presentation and DC migration towards and across
lymphatic endothelial barriers [13].
The in vivo requirement for HS-dependent presentation of
immobilized chemokines to enable directional leukocyte motility
in interstitial spaces was recently demonstrated [14]. The CCR7
chemokine, CCL21, was shown to form a steep gradient within the
perilymphatic dermal interstitium and to attract dermal dendritic
cells towards lymphatic vessels only when immobilized on HS
scaffolds and presented in an haptotactic gradient [14]. Interest-
ingly, this haptotactic CCL21 gradient, promoted highly direc-
tional DC migration, but neither its formation nor stability
required an additional gradient of HS scaffolds [14]. Similarly,
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steep gradients of immobilized CXCL8 that require HS scaffolds
can be generated in vivo, even though the HS containing surfaces
these chemokine gradients are generated on contain uniform HS
densities [17]. In lymph nodes, CCL21 gradients within the border
of B follicles and the T cell zone also form independently of HS
gradients [18]. These observations collectively suggest that in
tissues, gradients of chemokines immobilized on HS can be
generated and maintained primarily by confined chemokine
production by a single cell or group of adjacent cells.
In spite of these advances in the field of chemokine-directed
leukocyte migration, it is still unclear how chemokine gradients
form between basolateral and apical aspects of blood vessels to
promote directional leukocyte emigration across these vessels. On
one hand, the extensive blood flow exerted on apically bound
endothelial chemokines may fully account for the formation of a
net chemokine gradient between the lumenal (apical) and
ablumenal (basolateral) aspects of blood vessels. On the other
hand, there could be a second, non-mutually exclusive, mecha-
nism that helps sustain steep chemokine gradients between apical
and sublumenal aspects of endothelial barriers. To identify such a
mechanism, we employed several immunohistochemical ap-
proaches to study the distribution of HS around post capillary
venules. We found that different post capillary venules known to
support massive leukocyte trafficking pattern steep gradients of HS
moieties between their lumen and the basolateral aspects. Notably,
these HS gradient can be further amplified during inflammation
by the massive secretion of ECM proteoglycans decorated with
HS. These are in turn incorporated into the basal lamina, which is
remodeled by both the post capillary venules and their surround-
ing pericytes to provide HS GAG ‘‘carpets’’, on which both HS-
binding inflammatory chemokines and cytokines can be poten-
tially presented to recently extravasating leukocytes.
Materials and Methods
Animals
Female C57BL/6 wild-type mice were purchased from Harlan
laboratories (Rehovot, Israel). Heparanase knock-out mice were
generated and backcrossed as previously described [19], and were
a gift from Prof. I. Vlodavsky (Technion, Haifa). ROSAmT/mG
double-fluorescent Cre reporter mice [20] and CD11c-Cre
transgenic mice [21] were purchased from Jackson laboratory.
ROSAmT/mG transgenic mice [20] express membrane-targeted
tandem dimer Tomato (mT) prior to Cre-mediated excision, and
membrane-targeted green fluorescent protein (mG) after excision.
The ROSAmT/mG strain was crossed with the CD11c-Cre
transgenic mouse strain [21]. Mice were used at 8–12 weeks of
age. All inflammatory in vivo procedures were approved by the
Animal Research Committee at the Weizmann Institute of
Science.
Reagents and antibodies
Anti-HS monoclonal mouse IgM clone 10E4 was purchased
from Seikagaku Corporation (Tokyo, Japan) and from USBiolo-
gical Life Sciences (Salem, MA), goat anti-mouse VE-cadherin was
from R&D Systems (Minneapolis, MN), the BS1-B4 lectin, rabbit
anti-mouse laminin and FITC or Cy3 conjugated mouse
monoclonal antibodies to a-SMA were from Sigma-Aldrich (St.
Louis, MO). The MECA-79 hybridoma was a gift from Jean-
Philippe Girard (IPBS, Toulouse, France). Rabbit anti-mouse
LYVE1 was from Abcam (Cambridge, UK). The secondary
antibody Alexa-647 goat anti-mouse IgM was purchased from
Molecular Probes (Life Technologies, Carlsbad, CA). The
secondary antibodies donkey anti-mouse IgM Alexa-488 or 647,
donkey anti-goat Alexa-488 or 647, and donkey anti-rabbit
TRITC were purchased from Jackson Immunoresearch (West
Grove, PA). Hoechst 33342 and TRITC-phalloidin were pur-
chased from Sigma-Aldrich (St. Louis, MO). Horse serum was
from Vector Laboratories (Burlingame, CA). Complete Freund’s
adjuvant (CFA) was obtained from Difco (Detroit, MI). Hepari-
nase II was from Sigma-Aldrich (St. Louis, MO).
Skin inflammation model
Skin Inflammation was induced in the flank of 8–12 week old
female C57BL/6 recipient mice by three adjacent intradermal
injections of CFA (2.5 mg/ml, 20 ml per injection). Mice were
sacrificed 48 hours later and their inflamed skin tissue was
removed and fixed. Naı¨ve skin tissue was harvested from untreated
mice.
Immunofluorescence Procedures
Unless otherwise indicated, all skin sections were paraffin
embedded. Skin specimens were fixed in 4% PFA and embedded
in paraffin (4 mm sections). Target retrieval and deparaffinization
were performed using the target retrieval solution, pH = 9 (Dako,
Produktionsvej, Denmark) for 20 minutes at 95uC. Alternatively,
skin specimens were fixed in 1% PFA followed by 30% sucrose
and freezing. Cryostat skin sections (12 mm) were prepared and
fixed in ice cold acetone for 10 min. All sections were similarly
blocked with 10% horse serum, incubated with primary antibody
at 4uC overnight (HS, VE-cadherin and LYVE1 1:50, laminin
1:100, a-SMA 1:200, BS1–B4 1:20), washed, and incubated with
secondary antibody (1:100) for 40 minutes at RT. Skin sections
were imaged by a Delta-Vision microscope (Applied Precision,
Issaquah, Washington). Inguinal lymph nodes were fixed over-
night in buffer containing 0.05 M phosphate, 0.1 M l-lysine,
pH 7.4, 2 mg/ml NaIO4, and 10 mg/ml PFA, and then
dehydrated in consecutive sucrose gradients (10, 20, and 30% in
phosphate buffer). Tissues were snap frozen in OCT compound
Tissue-TekH (Sakura Finetek). Frozen sections (6 mm) were stained
with primary antibodies using the reagents and the protocol of the
M.O.M kit (Vector Labs, Burlingame, CA). For some experiments,
LN sections were pre-incubated for 60 min at 37uC with
Heparinase II (1.5 SU/50 ml) diluted in 1% BSA/PBS, and then
washed [14].
For analysis of HS deposition by skin derived endothelial cells
(ECs) in vitro, Human Dermal Microvascular Blood Endothelial
Cells (HDBEC) were cultured according to the supplier’s
instructions (Promocell Heidelberg, Germany), and plated at
confluence on glass-bottom dishes spotted with fibronectin (20 mg/
ml). ECs were stimulated with IL-1b (2 ng/ml) for 16–18 hours or
left unstimulated. Samples were fixed with PBS containing 4%
(wt/vol) paraformaldehyde and 2% (wt/vol) sucrose. For immu-
nostaining of the basement membrane deposited by the ECs, fixed
cells were permeabilized with saponin (0.1% (wt/vol)). Fixed cells
were extensively washed, blocked with 10% (vol/vol) goat serum
and incubated with primary antibody, followed by secondary
antibody incubated with the nuclear dye, Hoechst, and the F-actin
probe, phalloidin. Images were acquired using the Delta-Vision
system (Applied Precision, Issaquah, WA). Sections were acquired
as serial z stacks (0.2 mm apart) and were subjected to digital
deconvolution (SoftWoRx, Applied Precision).
Quantification of HS and BS1-B4 immunostaining
Fluorescence intensity was quantified with Image J (NIH). The
ratio of fluorescence staining within apical and basolateral blood
vessel compartments was extracted using a dedicated Matlab
(Mathworks, Natick, MA) program. Based on the fluorescently
Polarized Heparan Sulfate Distribution on Vessels
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labeled images, the algorithm quantified the red and green stained
regions in the apical and basolateral sides of each separate
endothelial cell, from which the area ratios for individual staining
was deduced. To compare HS thickness among multiple resting
and inflamed vessels, thickness values in the basolateral side of
individual vessels were quantified across many locations along the
vessel circumference using another dedicated Matlab program,
and mean thickness values were calculated for each vessel.
Statistical analysis
Reported values are expressed as mean with SEM (standard
error of the mean). Statistical analysis was performed by Prism 5
software (GraphPad Software, Inc. La Jolla, CA) using Student’s t-
test. P value of ,0.05 was considered significant.
Results
Resting skin vessels contain high HS densities at their
basolateral compartments
We first took a semi-quantitative approach to assess in vivo the
relative distribution of apical and subendothelial HS around
resting venules within the flank skin. In this tissue, endothelial cells
(ECs) can be readily depicted by VE-cadherin immunostaining,
and post capillary venules were distinguished from other blood
vessels by a-SMA immunostaining, since this protein is highly
elevated on pericytes associated with post capillary venules (Figure
S1). HS density and distribution were assessed with the pan HS
specific IgM mAb 10E4, which recognizes N-sulfated glucosamine
residues shared by all known HS GAGs [22]. Importantly, a
recent study suggested that this N-sulfation rather than O-sulfation
of the HS uronic acid moiety enables high affinity binding of
chemokines [23]. Furthermore, this mAb does not bind hyalur-
onan, chondroitin sulfate (CS), dermatan sulfate, or keratan sulfate
GAGs [22]. The specificity of this mAb was first confirmed in vitro
by lack of 10E4 staining of CHO cells, which are deficient in
xylosyl transferase and are unable to synthesize proteoglycans
(Figure S2). We next analyzed 10E4 specific staining in both
frozen and paraffin embedded sections from resting skin.
Strikingly, all post capillary venules as well as arterioles exhibited
much higher 10E4 reactivity at their basolateral compartments
(basal lamina) compared to the endothelial apical side (lumenal)
(Figure 1 and Figure S3). This HS high reactivity was detected
both at the interface between ECs and their associated pericytes,
as well as at the pericyte basolateral side (Figure 1E–H). This
staining pattern suggested that HS GAGs are highly enriched in
the basement membrane of skin post capillary venules, and raised
the possibility that these vessels exhibit a sharp HS density
gradient between their apical and sublumenal aspects.
Heparan sulfate is diminished in the proximal BS1-B4
positive endothelial glycocalyx
Endothelial cells are decorated with variably sized glycocalyx
layers composed of membrane bound glycoproteins and proteo-
glycans as well as non-covalently bound GAGs [24,25], which in
post capillary venules comprise an outer (distal) layer that can
extend up to 0.5 mm away from the plasma membrane [26]. We
first confirmed that the low HS content detected on the lumenal
aspects of skin blood vessels was not the result of loss of covalently
attached glycocalyx components from our samples. This was
supported by considerable staining of the ubiquitous a-gal epitope
detected by the BS1–B4 lectin (Figure 2A), a glycan probe used
extensively for in vivo visualization of the lumenal glycocalyx of
multiple types of blood vessels [27]. We next quantified the
fluorescence intensity along the axial blood vessel (Figure 2B), and
the pixel ratio of the apical to basolateral HS immunostaining, and
compared it to the pixel ratio of apical and basolateral a-gal
staining detected by the BS1-B4 lectin (Figure 2C). Whereas a-gal
staining was almost uniformly distributed on the apical and
basolateral compartments, HS staining was almost exclusively
localized to the basolateral aspect of the resting skin vessels
(Figure 2A–C). Collectively, our staining data strongly suggest that
the proximal glycocalyx monolayer covering resting post capillary
skin venules is largely devoid of HS, and that most of the HS
associated with these blood vessels is confined to the basement
membrane deposited by these blood vessels.
The HS content of the basement membrane of skin post
capillary venules is highly enriched under inflammatory
conditions due to extensive deposition of ECM
We next asked if inflamed skin vessels preserve the same HS
content and polarized distribution found in resting venules. A
progressive inflammation of the skin induced by local intradermal
injection of complete Freund’s adjuvant (CFA), resulted within
48 hours in swollen dermal tissue with substantial leukocyte
infiltration (Figure 3). Notably, extensive basolateral deposition of
HS was found around inflamed post capillary venules (Figure 4A–
C), but not around arteries, venules or lymphatic vessels (data not
shown). This massive HS enrichment in the basal lamina of
inflamed post capillary venules was accompanied by co-enrich-
ment of the basement membrane glycoprotein marker, laminin
(Figure 4D–I). Interestingly, the basement membrane of resting or
CFA inflamed skin post capillary venules did not contain
fibronectin, and the global distribution of this adhesive glycopro-
tein within the inflamed interstitium remained comparable to that
found in resting skin (data not shown), in contrast to reports on ear
skin subjected to delayed type hypersensitivity reactions [28].
Since the ECM HS is expressed by proteoglycans rather than by
glycoproteins [29], these results suggest that inflamed venules
secrete extensive amounts of both HS-containing ECM proteo-
glycans as well as glycoproteins. The high co-localization of both
HS moieties and laminin in disorganized networks also suggest
that this extensive ECM deposition is orchestrated both by the
inflamed ECs and their associated mural cells. Importantly, this
inflammation-induced HS enrichment was not associated with a
parallel increase in apical (lumenal) expression of HS moieties on
inflamed skin vessels (Figure 4A–C). Thus, inflamed skin post
capillary venules express much higher HS at their basolateral
aspects than on their apical aspects under both resting and
inflamed conditions.
HS deposition near inflamed skin vessels is not elevated
in mice deficient in the main HS degrading enzyme,
heparanase
Heparanase is a proinflammatory enzyme upregulated both
transcriptionally and translationally by TNF or IL-1b signals in
multiple types of cells including epithelial and ECs as well as in
leukocytes [30–32]. We therefore reasoned that heparanase
activities triggered within inflamed skin vessels and their
surrounding stromal cells, including infiltrating leukocytes, may
degrade the de novo deposited HS GAGs detected near inflamed
skin venules. We also predicted that elevated HS would be
detected near inflamed blood vessels of heparanase knock-out
mice. Surprisingly, however, both inflamed and resting skin post
capillary venules exhibited similar content and distribution of HS
moieties (Figure 5A–F). Thus, heparanase activity in skin
endothelium and in their closely associated stromal cells, as well
as infiltrating leukocytes does not appear to modulate either the
Polarized Heparan Sulfate Distribution on Vessels
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constitutively expressed or the de novo deposited HS GAGs in skin
tissues.
Human dermal microvascular blood endothelial cells
deposit HS mainly at their basolateral aspect in a cell
autonomous manner
The highly enriched HS detected at the basement membranes
of skin post capillary venules could arise from both endothelial
deposited HS, as well as pericyte secreted HS (Figure 1E–H). In
addition, the capacity of ECs to pattern HS gradients across their
apical and basolateral aspects could depend on paracrine signals
from pericytes and other perivascular cells. We therefore took an in
vitro approach to test whether the HS enrichment in the basement
membranes of skin blood vessels reflects a cell-autonomous
capacity of isolated cultured dermal ECs to deposit high HS
preferentially at their basement membranes. To that end, we
analyzed the HS distribution on either intact or permeabilized
confluent HDBEC monolayers with the 10E4 anti-HS IgM mAb.
Without permeabilization the accessibility of this large mAb to the
basolateral aspects of the endothelial monolayer was negligible,
such that the vast majority of the mAb specific staining was
constrained to the apical endothelial surface (Figure 6). After
endothelial permeabilization the IgM could readily access the
Figure 1. Resting skin vessels contain high density HS moieties preferentially expressed at their basolateral compartments. (A, C, E,
F, G) Axial and longitudinal sections of vessels of (A, B) naı¨ve frozen, or (C, D, E, F, G) paraffin embedded murine flank skin tissues. Tissues were stained
for HS with monoclonal mouse IgM (10E4 epitope; red), goat anti mouse VE-cadherin (cyan), FITC-mouse monoclonal to a-SMA (green), and nuclei
(blue). (H) HS and a-SMA profile of the fluorescence intensity along the purple arrow in the merged image. Double-headed black arrow denotes the
vessel lumen as indicated by VE-cadherin. In C, D and G, small-headed arrows denote the endothelial apical side, large-headed arrows denote the
endothelial basolateral side, and broken-line arrows denote the pericyte basolateral side. Images were taken at 100X magnification. Scale bar
represents 5 mm.
doi:10.1371/journal.pone.0085699.g001
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basolateral compartments of the endothelial monolayers. Using
this differential staining approach we detected much higher HS
staining within the basolateral aspects than on the apical aspects of
the HDBEC monolayers (Figure 6). Notably, the HS pattern,
distribution and level of expression detected by the 10E4 mAb
were not altered after IL-1b stimulation (Figure 6). Thus, the
dramatically elevated levels of HS deposited in vivo within the
basement membrane of inflamed skin post capillary venules
(Figure 4), likely reflect a combined contribution of HS secretion
by inflamed ECs, inflamed pericytes, as well as other perivascular
resident cells. Taken together these in vitro results suggest that the
capacity of ECs to pattern HS gradients between their apical and
basolateral aspects is cell autonomous. Furthermore, the in vitro
and in vivo results collectively suggest that the enhanced deposition
of HS rich ECM ‘‘carpets’’ during inflammation in vivo (Figure 4)
around skin vessels is contributed both by endothelial and non-
endothelial perivascular counterparts.
HS is highly enriched in the basal lamina of lymph node
HEVs
Lymph node HEVs are the primary post capillary venules that
support massive constitutive lymphocyte recruitment [33]. The
CCR7 chemokines CCL21 and CCL19 have been implicated in
lymphocyte recruitment and diapedesis across these vessels, and
Figure 2. Low HS content within the apical glycocalyx of resting murine flank skin vessels. (A) Paraffin embedded murine naı¨ve dermal
tissue immunostained for HS (red; left panel), glycocalyx (a-gal) with the lectin BS1-B4 (green; middle panel), and VE-cadherin (cyan). Images were
taken at 100X magnification. Scale bar represents 5 mm. (B) Glycocalyx and HS fluorescence intensity along the purple arrow in the merged image
(right panel). Double-headed black arrow denotes the vessel lumen as indicated by the apical glycocalyx. (C) Pixel ratio per cell (apical/basolateral as
indicated by the areas marked with white lines) in naı¨ve murine dermal tissue. Small-headed arrow denotes the endothelial apical side, large-headed
arrow denotes the endothelial basolateral side, and broken-line arrow denotes the pericyte basolateral side. Data are the mean value and S.E.M. of 16
endothelial cells analyzed in sections derived from three independent experiments. P,0.0001 by paired t-test.
doi:10.1371/journal.pone.0085699.g002
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surface-bound CCL21 has been reported to be highly enriched at
the basolateral aspects of HEVs [11,13]. The high levels of CCL21
and of other lymphocyte attracting chemokines, including
CXCL13 and CXCL12 within the basal lamina of HEVs were
attributed to their affinity for collagen IV [34]. Recent studies
suggested, however, a key involvement of HS biosynthesis by
HEVs in both T cell arrest and entry to resting lymph nodes,
consistent with a critical role of HS-dependent chemokine
presentation by these ECs in lymphocyte crossing of HEVs [13].
We therefore hypothesized that similar to skin post capillary
venules, a steep gradient of HS might exist between the apical and
basolateral aspects of lymph node HEVs. We therefore took a
similar HS staining approach to that used in the skin, but rather
than VE-cadherin staining, we used ROSAmT/mG CD11c-Cre
transgenic mice expressing ‘tomato’ and GFP markers to
distinguish HEVs from lymph node DCs. The ROSAmT/mG
strain was crossed with the CD11c-Cre transgenic mouse strain
[21] resulting in membrane-targeted green fluorescent protein
(mG) expression in all CD11c cells. The tomato reporter was
ubiquitously high on all blood vessels and could be easily
distinguished from the GFP labeled CD11c+ cells allowing
visualization of these two major cell types in fixed samples at
single cell resolution. As shown in Figure 7A–D, all HEVs of naive
inguinal lymph nodes appeared bright red, in contrast to the
abundant DCs surrounding these HEVs which appeared green.
Both membrane-targeted markers also highlighted membrane
structures, and permitted visualization of fine cellular processes
(Figure 7B). Thus, immunostaining of these sections with the HS
specific mAb 10E4 allowed us to determine at high spatial
resolution the density of HS moieties found on either the apical
and sublumenal interface of the bright red ECs. Specificity of the
mAb staining was confirmed by total loss of 10E4 staining after
Heparinase II digestion (Figure S4). As observed in the skin,
almost all the HS detectable around HEVs was localized to the
basal lamina deposited by these cells, with essentially undetectable
HS staining on the lumenal aspects (Figure 7A, B). In agreement
with their enrichment in the basal lamina, HS staining colocalized
with laminin (Figure 7C, D). Interestingly, no BS1-B4 staining
could be detected on either the apical or the basolateral aspects of
HEVs (data not shown), suggesting major differences in the
biochemical composition of the glycocalyx surrounding the skin
versus the lymph node post capillary venules. We therefore used
MECA-79 as a specific marker of the HEV glycocalyx. As
expected, MECA-79 stain was noted on all HEVs and this
glycocalyx layer was clearly distinguished from the endothelial cell
body and enriched at the lumenal, junctional and basolateral
aspects of individual HEVs (Figure 8D–F). Nevertheless, no HS
staining could be found on the lumenal side of HEVs (Figure 8A–
C), as could also be seen by the quantification of the fluorescence
intensity along the axial blood vessel (Figure 8G), further
substantiating the restricted expression of HS in the HEV
basement membrane. These results collectively suggest that
although biochemically distinct in their glycan composition, both
non lymphoid and lymphoid post capillary venules share a similar
pattern of highly enriched HS GAGs concentrated at the
basolateral (ablumenal) aspects of these vessels.
Discussion
Cytokine stimulated post capillary venules are the major blood
vessels through which leukocytes traffic into tissues [4]. Multiple
adhesive ligands cooperate with chemokines presented on both the
apical and basolateral aspects to coordinate leukocyte adhesion to,
and motility on and across the endothelial barriers that comprise
these vessels. It is believed that net chemotactic gradients between
the apical and basolateral aspects of the post capillary venules are
essential for the highly directional nature of leukocyte diapedesis
across the vessel wall, but the evidence for such net gradients is still
weak.
Figure 3. H&E staining of naı¨ve and inflamed flank skin. (A) Naı¨ve or (B) inflamed murine dermal tissue was stained and images were taken at
10X magnification. Scale bar represents 200 mm.
doi:10.1371/journal.pone.0085699.g003
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Despite the growing evidence that immobilized rather than
soluble chemokines are the functional chemoattractive unit critical
for directional leukocyte migration in the interstitium [14], it has
been unclear to date whether and how soluble and surface
immobilized chemokines produced by ECs and their adjacent
stromal cells generate and maintain stable gradients across blood
vessels i.e., from the apical to the basolateral aspects of blood vessel
barriers, thereby promoting leukocyte diapedesis [35]. Notably,
surface bound chemokine gradients can form in interstitial spaces
containing uniform HS scaffolds [17], and thus, the generation of
such gradients seems to depend on local chemokine production as
well as on rapid degradation, deactivation, or scavenging of excess
chemokines [36]. In contrast, endothelial produced or transported
chemokines can be readily washed from the lumenal aspects of
blood vessels by blood flow, and therefore, pure mass action may
be sufficient to sustaining sharp gradients between apical and
basolateral endothelial surfaces. Here, we provide the first
evidence of an additional regulatory mechanism to generate and
sustain stable chemokine gradients, employed by multiple types of
ECs; this mechanism involves robust HS enrichment within the
basement membranes of both resting and inflamed post capillary
venules.
Our present study puts in perspective several previous findings
that indicated strong HS GAG staining around ECs [13,15,37].
Due to low resolution, the relative distribution of HS GAGs
around the blood vessels studied in these reports appeared to be
uniformly expressed on both flat ECs and in lymph node HEVs.
The improved resolution attained here, allowed us to differentiate
between the endothelial cell body and its immediate glycocalyx
and ECM in these two prototypic post capillary venules, and led us
Figure 4. HS and laminin are massively deposited in the basement membrane of inflamed skin vessels. (A) Longitudinal and (B) axial
paraffin sections of representative post capillary venules of CFA inflamed skin. (C) VE-cadherin and HS profile of the fluorescence intensity along the
purple arrow in the axial section. Double-headed black arrow denotes the vessel lumen as indicated by VE-cadherin. In B, small-headed white arrow
denotes the endothelial apical side. (D, E, F) Sections of naı¨ve, and (G, H, I) inflamed murine dermal tissue, immunostained for HS (red), VE-cadherin
(cyan), laminin with rabbit anti-mouse (green), and nucleus (blue). (F, I) merged images. Images were taken at 100X magnification. Scale bar
represents 5 mm.
doi:10.1371/journal.pone.0085699.g004
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to conclude that endothelial HS is mainly concentrated within the
basal lamina the endothelial monolayer. Thus, in addition to their
well-known cytokine storage activity, mechanical stabilizing
functions [38], as well as restricting endothelial permeability to
transport of solutes and proteins [39], basement membrane HS
proteoglycans deposited by ECs may be critical for the proper
positioning of HS-binding chemokines to leukocyte protrusions
which scan endothelial junctions for exit cues [40,41]. Basement
membrane HS GAGs may also protect chemokines secreted by
endothelial, perivascular stromal cells, as well as recently
transmigrating leukocytes from proteolytic degradation [42].
Endothelial glycocalyx composition and structure within intact,
inflamed and enzyme-treated blood vessels [43] was previously
compared by multiple approaches including in vivo dextran
exclusion measurements, lectin staining, fluorescence microparti-
cle image velocimetry [44], as well as lanthanum-based electron
microscopy [45]. These studies suggest that this highly hydrated
gel-like structure is composed of two main layers: a compact inner
layer ,100 nm above the apical membrane surface, and an outer
layer ranging up to 0.5 mm away from the plasma membrane [26].
This outer layer contains extended core proteins, mechanically
stabilized by HS and CS GAGs [24,29,43,46], and continuously
secretes HA chains that are non-covalently tethered to the apical
endothelial CD44 [24]. Multiple inflammatory signals have been
traditionally suggested to induce the shedding of this endothelial
glycocalyx layer, and such shedding may be necessary for the
exposure of transmembranal adhesion molecules ordinarily
masked by endothelial glycocalyx [27,31,43,47–49]. The mem-
brane proximal glycocalyx layer, on the other hand, is composed
of both non GAG glycoproteins as well as membrane-bound GAG
proteoglycans such as HS and CS, containing syndecans and
glypicans, which connect to the endothelial cortical cytoskeleton or
to apical endothelial caveolae, respectively [24]. Due to its small
dimensions, this thinner layer is probably the exclusive layer
through which rolling leukocytes can encounter and establish
Figure 5. HS deposition is not elevated in mice deficient in the main HS degrading enzyme, heparanase. (A, C) Naı¨ve, or (B, D) inflamed
murine dermal tissue were removed from (A, B) wt or (C, D) heparanase KO mice, embedded in paraffin, and immunostained for HS (red), VE-
cadherin (cyan), and nucleus (blue). Images were taken at 100X magnification. Scale bar represents 5 mm. In A the small-headed arrow denotes the
endothelial apical side, the large-headed arrow denotes the endothelial basolateral side, and the broken-line arrow denotes the pericyte basolateral
side. HS thickness (mm) in naı¨ve (E), and inflamed (F) murine dermal vessels of either wt or heparanase KO mice. Data in each experimental group are
mean value with SEM of 8 vessels in sections derived from three independent experiments.
doi:10.1371/journal.pone.0085699.g005
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adhesive interactions with their endothelial expressed integrin
ligands.
In our hands, considerable BS1–B4 staining was readily
detectable within a layer 0.3–0.5 mM away from the endothelial
cell body, demonstrating that the fixation protocols used by us
retained considerable fraction of the endothelial glycocalyx. This
notion allows us to conclude that the apical glycocalyx layer of skin
post capillary venules contains much lower HS content than the
HS moieties deposited within the basolateral endothelial com-
partment of these vessels, both under resting and inflamed
conditions.
In spite of their low density and large distance from the plasma
membrane, specialized apical endothelial HS moieties, must be
able to stably present, alone or with another scaffold molecule such
as DARC or a related molecule [50,51], sufficient HS binding
chemokine molecules to rolling leukocytes so they can activate
their integrins and arrest on the target endothelial surface. The low
availability of apical HS GAG scaffolds for chemokines identified
by us in the present work raises the possibility that once arrested
on the apical endothelial membrane, some leukocytes may need to
integrate post arrest signals from endothelial produced or
transcytosed chemokines in an HS independent manner, i.e. via
confined release of intra-endothelial chemokine pools within
submicron synapses generated by the endothelial adherent
leukocytes and the endothelial surface they serially engage [52].
These pools of chemokines may be particularly efficient in their
ability to locally activate leukocyte GPCRs, and trigger leukocyte
protrusions at the apical endothelial surface. A subset of these
protrusions would then transverse the endothelial junctions and
respond to basolateral chemokines presented by the dense HS
moieties of the endothelial basement membrane.
Although inflammatory conditions were suggested to increase
HS degradation by its main degrading enzyme, heparanase, our
studies in the inflamed skin suggest that inflammation in fact
dramatically elevates HS and laminin deposition by post capillary
venules. Furthermore, although heparanase levels and activities
Figure 6. HS is localized mainly to the basement membrane in both resting and inflamed human dermal microvascular blood
endothelial cells (HDBECs). Immunostaining for HS (red), actin (green) and nuclei (blue) of resting or IL1-b- stimulated HDBEC monolayers grown
for 16–18 hours on fibronectin. The mean fluorescence intensity values shown are the mean6SEM of ten fields of view from three independent
experiments. Images were taken with a Delta-Vision microscope at 60X magnification. Scale bar represents 15 mm. N.S. not significant. ***P,0.0001
by Student’s t test.
doi:10.1371/journal.pone.0085699.g006
Figure 7. HS is highly enriched in the basal lamina of lymph
node HEVs. (A, B) Cryosections of naı¨ve lymph nodes derived from
ROSAmT/mG 6 CD11c-Cre reporter mice immunostained for HS (grey).
CD11c+ cells express the GFP protein (green), and endothelial cells
express high levels of the tomato protein reporter (red). (C, D)
Immunostaining of similar lymph node sections for HS (grey) and
laminin (red). In B, small-headed arrow denotes the endothelial apical
side as indicated by the tomato staining, and large-headed arrow
denotes the endothelial basolateral side. Images were taken at (A) 10X
magnification (scale bar represents 100 mm), and (B, C, D) 63X
magnification; scale bars represent 10 mm.
doi:10.1371/journal.pone.0085699.g007
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are upregulated in many inflammatory settings [53–55], and in vivo
siRNA silencing of heparanase induces heparanase dependent
changes in skin vessel permeability [53], this massive deposition of
HS containing proteoglycans near inflamed vessels is not mitigated
by heparanase activity. Thus, both at steady state and after
induction of local skin inflammation, both heparanase knock-out
mice and wt mice shared similar HS enrichment near skin blood
vessels suggesting that this enzyme is not functional within resting
or inflamed skin vessels.
In conclusion, our results support the notion that both
peripheral and lymph node post capillary venules preferentially
express HS-containing scaffolds within their respective basement
membranes, rather than in the thin plasma membrane glycocalyx
decorating the immediate adhesive layer formed by their
transmembranal glycoproteins. Importantly, this pattern of highly
polarized HS expression seems to be conserved in multiple types of
post capillary venules. Together with the extensive washing of
chemokines presented on the lumenal endothelial aspects, this
polarized HS expression may be responsible for the generation of
chemokine gradients between the lumenal and basolateral aspects
of blood vessel barriers that participate in leukocyte recruitment to
target tissues. During inflammation, post capillary venules in the
skin and possibly in other inflamed tissues can further enrich the
HS content of their perivascular compartments, generating
additional HS scaffolds in the form of HS rich ECM ‘‘carpets’’.
This highly polarized production of HS GAGS may result in two
major physiological outcomes: it could help blood vessels sustain a
net gradient of HS scaffolds for chemokines that bind surface
GAGs, and thereby sustain steep chemokine gradients for
leukocytes emigrating across inflamed vessels; in addition, this
dense perivascular HS patterned by post capillary venules may
also present key pro-inflammatory cytokines to recently emigrated
leukocytes. These HS GAGs may contribute to the capacity of
such cytokines to reprogram the navigation and effector machin-
Figure 8. Differential distribution of HS and of PNAds in lymph node HEVs. Consecutive sections of lymph node cryosections of the
ROSAmT/mG6CD11c-Cre reporter mice stained for (B, C) HS (grey), or (E, F) PNAd (grey) using the 10E4 or MECA-79 IgMs, respectively. (A, C, D, F)
Note the intense tomato protein label on the HEVs (red). (C, F) Merged images. (G) HS and MECA-79 profile of the fluorescence intensity along the
purple arrow. Double-headed black arrow denotes the vessel lumen as indicated by the tomato staining. In C, small-headed arrow denotes the
endothelial apical side, and large-headed arrow denotes the endothelial basolateral side. Images were taken at 63X magnification. Scale bars
represent 10 mm.
doi:10.1371/journal.pone.0085699.g008
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eries of emigrating leukocytes [56] as they pass through the basal
lamina. Further dissection of their composition and functions may
therefore identify novel targets for anti-inflammatory therapy.
Supporting Information
Figure S1 a-SMA staining is observed around post
capillary venules and arterioles, but not near lymphatic
vessels. Immunofluorescence of (A) post capillary venule, (B)
arteriole, and (C) lymphatic vessel of naı¨ve murine skin. (A, B, C)
Paraffin sections stained with FITC-mouse monoclonal to a-SMA
(green), goat anti-mouse VE-cadherin (cyan), nuclei (blue), (C)
rabbit anti mouse LYVE1 (blue). Images were taken at 100X
magnification. Scale bar represents 5 mm.
(TIF)
Figure S2 10E4 staining of WT and proteoglycan-
deficient CHO cells. (A) WT and (B) HS deficient CHO cells
stained for HS (red) and nuclei (blue). Images were taken at 20X
magnification. Scale bar represents 40 mm.
(TIF)
Figure S3 Arterioles deposit HS at their basolateral
compartment. An arteriole in paraffin section of naı¨ve murine
skin, stained for a-SMA (green), HS (red), VE-cadherin (cyan) and
nuclei (blue). (C) Merged image. Images were taken at 100X
magnification. Scale bar represents 5 mm.
(TIF)
Figure S4 Elimination of HS staining in lymph node
HEVs after Heparinase II digestion. Lymph node cryosec-
tions of the ROSAmT/mG x CD11c-Cre reporter mice stained for
HS (grey) (A) without, or (B) after Heparinase II treatment.
CD11c+ cells express the GFP protein (green). Endothelial cells
express high levels of tomato protein reporter (red). Images were
taken at 25X magnification. Scale bars represent 50 mm.
(TIF)
Data S1 Cell culture conditions of Chinese hamster
ovary (CHO) cells.
(DOCX)
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